Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The objective of this study is to better understand the structural and functional changes that the CNS undergoes following stroke and how these changes relate to clinical measures. Both macroscopic and microscopic changes of the brain and the spinal cord will be examined in stroke patients and compared to healthy controls. In terms of structural plasticity, we aim to identify MR biomarkers that allow predicting the course of the patient's neurological status and accurately describe the course of the disease and the recovery. Importantly, we aim to investigate which factors scale the patients' symptoms.
In terms of functional plasticity, we will combine fMRI with behavioural motor and sensory testing to understand i) the structural and functional interplay between spinal and supraspinal neural circuits after stroke possibly driven by beneficial plasticity/regeneration vs. maladaptive plasticity/degeneration and ii) which clinical and behavioural determinants drive functional hand representations in the primary somatosensory and motor cortices to be maintained and which determinants drive reorganisation of functional representations following sensory input loss. We will further investigate the contribution of brainstem reorganisation to plasticity observed at the cortical level and, by doing so, aim to better understand the mechanistic underpinnings of functional reorganisation.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Patients with stroke |
| ||
| Healthy subjects |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| MRI | Diagnostic Test | We will examine chronic (>3 months post stroke) patients using functional, structural, and metabolic MRI in both the brain and the spinal cord. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Conventional magnetic resonance imaging (MRI) parameter | Structural characteristics in the brain and spinal cord are assessed in chronic stroke patients using conventional MRI and compared to healthy controls | Up to 50 weeks] |
| Measure | Description | Time Frame |
|---|---|---|
| Magnetic resonance spectroscopy (MRS) parameter | Metabolic parameter are assessed in chronic stroke patients using MRS in the brain and spinal cord and compared to healthy controls | Up to 50 weeks |
| Functional MRI (fMRI) parameter |
Not provided
Inclusion Criteria - Patients:
Exclusion Criteria - Patients:
Inclusion Criteria - Healthy subjects:
Exclusion Criteria - Healthy subjects:
Not provided
Not provided
Patients with stroke and healthy subjects.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Maryam Seif, PD Dr. | Contact | +41 44 510 72 14 | maryam.seif@balgrist.ch | |
| Sanne Kikkert | Contact | +41 44 633 32 94 | sanne.kikkert@balgrist.ch |
| Name | Affiliation | Role |
|---|---|---|
| Patrick Freund, Prof. Dr. | University of Zurich | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Universitätsklinik Balgrist | Recruiting | Zurich | 8008 | Switzerland |
Not provided
| ID | Term |
|---|---|
| D020521 | Stroke |
| ID | Term |
|---|---|
| D002561 | Cerebrovascular Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| MRI | Diagnostic Test | We will examine healthy control participants using functional, structural, and metabolic MRI in both the brain and the spinal cord. |
|
Brain activity or change of brain activities between 2 to 5 time points is assessed using fMRI during resting-state or a specific task in chronic stroke patients and compared to healthy controls
| Up to 50 weeks |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |